Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4546146
Max Phase: Preclinical
Molecular Formula: C10H13ClFNO4S2
Molecular Weight: 329.80
Molecule Type: Unknown
Associated Items:
ID: ALA4546146
Max Phase: Preclinical
Molecular Formula: C10H13ClFNO4S2
Molecular Weight: 329.80
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CN(C)S(=O)(=O)c1cc(CCS(=O)(=O)F)ccc1Cl
Standard InChI: InChI=1S/C10H13ClFNO4S2/c1-13(2)19(16,17)10-7-8(3-4-9(10)11)5-6-18(12,14)15/h3-4,7H,5-6H2,1-2H3
Standard InChI Key: QEVKEOBBBAHZIR-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 329.80 | Molecular Weight (Monoisotopic): 328.9959 | AlogP: 1.43 | #Rotatable Bonds: 5 |
Polar Surface Area: 71.52 | Molecular Species: | HBA: 4 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 1.34 | CX LogD: 1.34 |
Aromatic Rings: 1 | Heavy Atoms: 19 | QED Weighted: 0.77 | Np Likeness Score: -1.48 |
1. Xie Y, Tummala P, Oakley AJ, Deora GS, Nakano Y, Rooke M, Cuellar ME, Strasser JM, Dahlin JL, Walters MA, Casarotto MG, Board PG, Baell JB.. (2020) Development of Benzenesulfonamide Derivatives as Potent Glutathione Transferase Omega-1 Inhibitors., 63 (6): [PMID:32105470] [10.1021/acs.jmedchem.9b01391] |
Source(1):